Skip to content
Demo
Creator Hubs›Carevive

Carevive

Carevive logo

Remote oncology monitoring that connects clinicians and cancer patients between visits.

Carevive is an oncology health technology company that gives care teams a remote patient monitoring platform to track symptoms, collect patient-reported outcomes, and manage cancer patients between clinic visits. The system is designed to surface actionable data for clinicians while reducing the burden on patients managing complex treatment regimens. On MarketScale, Carevive publishes content for oncology administrators, clinicians, and health systems evaluating remote care management tools.

79 episodes
Channel Brief·Carevive · 79 episodes
Updated Jan 9, 2023

Patient data drives oncology care redesign and revenue

Carevive argues that real-time, longitudinal patient-reported outcomes reshape how oncology centers operate under new payment models. The channel supplies concrete patient cases and registry scale as proof.

Carevive's core argument is that oncology care improves when clinicians receive continuous, real-time patient experience data integrated directly into their workflows, not periodic snapshots from claims or lab results. The channel demonstrates this through patient grand rounds examples, registry analytics spanning 26 cancer types, and longitudinal survey compliance data that show how symptom alerts and alert triggers prompt care team intervention and reduce hospitalizations.

Drawn from Carevive’s Longitudinal Data and 2 more →

“Integrating patient-reported outcomes into the workflow leads to improved patient adherence to therapy and reduced hospitalizations and emergency room visits.”

CV/COS Webinar: Clip 11

By the numbers

600,000

unique data points from 19,000 surveys over two years

1,700

patients represented across 26 cancer types in registry

19,000

completed surveys conducted over two years

26

cancer types covered in Carevive platform

What the channel argues

DataCarevive's registry captures over 1,700 patients across 26 cancer types with 19,000 surveys yielding 600,000 data points.→
DataEOM replaces OCM beginning July 1, 2023, supporting care for seven common cancer types with focus on health equity.→
InsightAlert triggers for moderate to severe symptoms enable care teams to intervene promptly and document care responses.→
InsightPatient compliance with survey follow-ups is highest during the critical first three months of active treatment.→
InsightNSCLC patients report cost of care and treatment decision-making as top concerns, requiring data-driven insights.→

What you'll learn

•Real-world patient data collected at point of care complements clinical trials by representing the full disease population, not just the healthiest patients.
•The Oncology Care Model transition to Enhanced Oncology Model creates revenue opportunities through improved quality metrics and health equity focus.
•Patient-reported outcome platforms drive clinical utility when they generate actionable alerts, temporal summaries, and seamless EHR integration rather than passive data collection.
•Early-stage cancer patients have different symptom and functional needs than metastatic patients, requiring stage-specific data analysis for tailored care.

What to do about it

→Audit your oncology practice's readiness for EOM compliance by July 2023, focusing on seven common cancer types and health equity reporting.
→Deploy a patient-reported outcome system with alert triggers for moderate to severe symptoms to enable proactive symptom management and reduce emergency interventions.
→Leverage longitudinal patient data from your patient population to inform clinical trial design and post-marketing surveillance, grounding PRO measure selection in contemporary real-world evidence.

Who and what shows up

Dr. Aaron Galaznik

Chief Scientific Officer, Carevive

Hosted NSCLC SmartData webinar and led CV/COS webinar series, presenting Carevive's registry scale, alert system design, and longitudinal breast cancer analysis.

John Elliot

VP of Sales, Carevive

Interviewed on OCM-to-EOM transition and revenue-enhancing opportunities, representing sales perspective on model implementation.

Dr. Ethan Basch

Expert in digital remote monitoring

Led September 2022 webinar on electronic patient-reported outcomes implementation, troubleshooting provider and patient engagement challenges.

Questions this channel answers

Q

What is the difference between OCM and EOM, and why does it matter for our revenue?

OCM launched in 2016 to transition oncology centers from fee-for-service to high-value care. EOM replaces it July 1, 2023, extending support to seven cancer types with added focus on health equity and accountable, affordable care, opening new revenue-enhancing opportunities.

The New Oncology Model Created to Improve Cancer Care →
Q

How does patient data improve clinical outcomes in real practice?

Integrating patient-reported outcomes into clinical workflows enables timely symptom interventions, improved therapy adherence, reduced hospitalizations, and emergency room visits. Alert triggers on moderate to severe symptoms allow care teams to reach out and manage symptoms proactively.

Patient Engagement and Compliance →
Q

Why is longitudinal patient data better than claims or trial data alone?

Big data from claims provides only discrete sequential snapshots of health status. Longitudinal patient-reported data captures continuous patient experience during treatment, revealing symptom burden, treatment bother, and functional impact that guide personalized care decisions.

Improving the Patient Experience in Cancer →
Q

How can our center use patient data for clinical trial design?

Real-world data from standard-of-care populations offers contemporary, FDA-relevant domains for PRO measure selection, unlike outdated historical trial data. This data also bridges real-world and clinical trial populations, helping trials assess proximal and distal outcomes meaningful to patients across disease stages.

CV/COS Webinar: Applications and Future Directions →
Topics:Patient-reported outcomes (PRO) in oncologyEnhanced Oncology Model (EOM) payment transitionReal-world data and clinical trialsRemote symptom monitoring and alertsCancer stage-specific patient experiences
Themes:Patient voice as clinical dataReal-world evidence for payment and trial designWorkflow integration as adoption engine

Industry context

Real-world data from sources like electronic health records and patient-reported outcomes increasingly fills gaps left by clinical trials, which enroll only about 5% of cancer patients, enabling evidence generation for treatment decisions across diverse populations.

Want a show like this for your brand?

MarketScale produces and distributes branded shows like Carevive for B2B companies.

Book a Demo →